Intraosseous Infusion for Neonatal Asphyxiated Resuscitation

NCT ID: NCT01866358

Last Updated: 2018-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intraosseous infusion is better than umbilical vein infusion for neonatal asphyxiated resuscitation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asphyxia Neonatorum

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Umbilical vein infusion

using umbilical vein infusion for resucitation

Group Type PLACEBO_COMPARATOR

Umbilical vein infusion

Intervention Type PROCEDURE

Using umbilical vein infusion for resustation in this group

Intraosseous infusion

using intraosseous infusion for resucitation

Group Type EXPERIMENTAL

Intraosseous infusion

Intervention Type PROCEDURE

Using intraosseous infusion for resustation in this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intraosseous infusion

Using intraosseous infusion for resustation in this group

Intervention Type PROCEDURE

Umbilical vein infusion

Using umbilical vein infusion for resustation in this group

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* newborns who need resucitation

Exclusion Criteria

\-
Minimum Eligible Age

28 Weeks

Maximum Eligible Age

42 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Third Military Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lixue

director,head nurse of pediatric department ,principal investigator ,clinical professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shi Yuan, PhD

Role: STUDY_CHAIR

Professor, Chief of Pediatric Department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pediatrics of Daping Hospital

Chongqing, Chongqing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Wanglan

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.